🕒 Thursday 18 September 2025 Thu, 18 Sept 2025

Western Gold Resources Limited has had its trading suspension lifted following the release of initial assay results from its Duke Gold project and a response to an ASX price and volume query.

Western Gold Resources has responded to ASX inquiries about recent unusual trading activity, disclosing partial assay results from its Gold Duke drilling program while affirming compliance with continuous disclosure rules.

Western Gold Resources has completed over 45% of its 35,300-metre grade control and infill drilling program at the Gold Duke Project, receiving initial assay results from the Eagle prospect. The company is finalizing an updated scoping study and secured $3 million in non-dilutive funding to support a planned mining start in late 2025.

Tempest Minerals has secured regulatory approval to begin Phase I drilling at its Halo prospect within the Yalgoo Project, targeting iron, copper, and gold. A heritage survey with the Badimia People is currently in progress, marking a key step toward unlocking the site's potential.

Highfield Resources has requested a voluntary suspension of its shares on the ASX to complete a capital raising, with trading expected to resume by 23 September 2025.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Prospech Limited’s PRSO securities have been suspended from trading pending compliance with ASX rules, raising questions about the company’s regulatory standing.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

Mont Royal Resources Ltd (ASX – MRZ) has lodged a prospectus to raise between A$8 million and A$10 million through a share offer priced at A$0.20 each, coinciding with a proposed merger with Commerce Resources Corp (TSXV – CCE). The combined entity aims to become a leading Quebec-focused critical minerals developer.

Renascor Resources has begun construction of its Purified Spherical Graphite demonstration facility in Adelaide, aiming to showcase an innovative HF-free purification process and disrupt China’s near-monopoly on PSG supply.

PARKD Limited has clinched exclusive national rights to prefabricate key modular building components from Fielders, positioning itself to capitalize on booming construction sectors like data centres and self-storage across Australia.

Litchfield Minerals has successfully raised $1.5 million through an oversubscribed placement and share purchase plan, fueling an ambitious 14-hole drilling campaign at its flagship Oonagalabi Project.

Breakthrough Minerals is set to begin a Reverse Circulation drilling campaign at its 100% owned Errolls Gold Project in Western Australia, targeting extensions of previously identified high-grade gold mineralization. Recent soil sampling reinforces the project's prospectivity along the Youanmi Shear Zone.

Lithium Universe Limited reports a major advance in silver recycling technology, achieving near-Britannia-grade purity in just five minutes using its proprietary JESE method. This innovation promises to reshape solar panel recycling with higher efficiency and sustainability.

EQ Resources Limited has appointed industry veteran Craig Bradshaw as Managing Director, marking a strategic leadership transition to drive growth in global tungsten mining.

Argent Minerals has reported outstanding high-grade silver and polymetallic mineralisation from diamond drillhole AKDD208 at its Kempfield Project, significantly enhancing the deposit’s resource potential.

Forrestania Resources has completed its acquisition of the British Hill Gold Project near Southern Cross, Western Australia, and appointed MBS Environmental to lead mine development planning.

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Barton Gold has launched an 18,000m drilling campaign at its Tunkillia project to upgrade mineral resources and fast-track a mining lease application by 2026, targeting robust early cash flows from high-value starter pits.

Stakk Limited has secured a pivotal two-year agreement to provide embedded finance technology for Robinhood’s new banking service, marking a significant milestone for both fintech players.

Marvel Gold Limited has identified significant gold soil anomalies over a 3-kilometre stretch at its Hanang Gold Project in Tanzania, setting the stage for a maiden drilling campaign following a planned drone-borne magnetic survey.

Imricor Medical Systems has successfully completed a comprehensive Human Factors study for all its devices under FDA review, marking a critical milestone towards U.S. market entry. The extensive 7-month study involved 46 healthcare professionals and tested nine products, underscoring Imricor’s growing momentum in electrophysiology innovation.

Larvotto Resources has officially begun upgrading its Hillgrove processing plant in New South Wales, aiming for mid-2026 completion and a significant increase in antimony and gold production.